Navigating Commercial Logistics For Cell And Gene Therapies: A Roadmap To Scalable, Patient-Centered Success

When bringing cell and gene therapies (CGTs) to market, the unique and complex logistics involved are often the most significant challenge. Unlike traditional pharmaceuticals, these therapies demand precise temperature control, strict patient-specific handling, and seamless coordination across multiple partners.

The key to success is building a robust, resilient supply chain that can scale with demand while keeping the patient at the center. This requires a foundation of early, collaborative planning, integrating a digital infrastructure for real-time visibility, and preparing for global expansion. By prioritizing these elements, manufacturers can create a roadmap to commercial success that ensures therapies reach patients safely and on time.